ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityActive in the last 2 years
Dongwei Hu
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2023: 1 paper · 2024: none · 2025: 1 paper
Papers 2
- CALB2 facilitates macrophage M2 polarization to promote the growth and metastasis of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.cellsig.2025.111887↗
- CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L. First author DOI 10.1080/15384047.2023.2216041↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zongjing Chen · 2 shared papers, 2023–2025 · strength 0.49
- Paper CALB2 facilitates macrophage M2 polarization to promote the growth and metastasis of pancreatic adenocarcinoma. DOI 10.1016/j.cellsig.2025.111887↗
- Paper CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L. DOI 10.1080/15384047.2023.2216041↗
- Wei Liu · 2 shared papers, 2023–2025 · strength 0.49
- Paper CALB2 facilitates macrophage M2 polarization to promote the growth and metastasis of pancreatic adenocarcinoma. DOI 10.1016/j.cellsig.2025.111887↗
- Paper CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L. DOI 10.1080/15384047.2023.2216041↗
- Bo Xu · 2 shared papers, 2023–2025 · strength 0.49
- Paper CALB2 facilitates macrophage M2 polarization to promote the growth and metastasis of pancreatic adenocarcinoma. DOI 10.1016/j.cellsig.2025.111887↗
- Paper CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L. DOI 10.1080/15384047.2023.2216041↗
- Zhengde Wen · 1 shared paper, 2025 · strength 0.27
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.